AR022912A1 - Una cepa de las bacterias de acido lactico que forman parte del genero lactobacillus, el uso de la misma para preparar alimentos y las formulacionesalimenticias y farmaceuticas que la contienen - Google Patents

Una cepa de las bacterias de acido lactico que forman parte del genero lactobacillus, el uso de la misma para preparar alimentos y las formulacionesalimenticias y farmaceuticas que la contienen

Info

Publication number
AR022912A1
AR022912A1 ARP000101088A ARP000101088A AR022912A1 AR 022912 A1 AR022912 A1 AR 022912A1 AR P000101088 A ARP000101088 A AR P000101088A AR P000101088 A ARP000101088 A AR P000101088A AR 022912 A1 AR022912 A1 AR 022912A1
Authority
AR
Argentina
Prior art keywords
strain
food
lactic acid
same
acid bacteria
Prior art date
Application number
ARP000101088A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of AR022912A1 publication Critical patent/AR022912A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/36—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G9/363—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • Cereal-Derived Products (AREA)

Abstract

Se describen nuevos microorganismos del género Lactobacillus, que son utiles para prevenir la diarrea producida por bacterias patogenas. En particular, lapresente se relaciona con el uso de dichos microorganismos en la preparacion de un soporte ingerible y para una formulacion que los contiene.
ARP000101088A 1999-03-11 2000-03-10 Una cepa de las bacterias de acido lactico que forman parte del genero lactobacillus, el uso de la misma para preparar alimentos y las formulacionesalimenticias y farmaceuticas que la contienen AR022912A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99104922A EP1034787A1 (en) 1999-03-11 1999-03-11 Lactobacillus strains preventing diarrhea caused by pathogenic bacteria

Publications (1)

Publication Number Publication Date
AR022912A1 true AR022912A1 (es) 2002-09-04

Family

ID=8237746

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101088A AR022912A1 (es) 1999-03-11 2000-03-10 Una cepa de las bacterias de acido lactico que forman parte del genero lactobacillus, el uso de la misma para preparar alimentos y las formulacionesalimenticias y farmaceuticas que la contienen

Country Status (23)

Country Link
US (1) US6835376B1 (es)
EP (2) EP1034787A1 (es)
JP (1) JP2002537865A (es)
CN (1) CN1350461A (es)
AR (1) AR022912A1 (es)
AU (1) AU779414B2 (es)
BR (1) BR0008911A (es)
CA (1) CA2364435A1 (es)
CO (1) CO5241327A1 (es)
CZ (1) CZ20013264A3 (es)
HK (1) HK1042657A1 (es)
HU (1) HUP0200205A3 (es)
ID (1) ID30438A (es)
IL (2) IL145079A0 (es)
MY (1) MY125941A (es)
NO (1) NO20014299L (es)
NZ (1) NZ513806A (es)
PE (1) PE20001557A1 (es)
PL (1) PL355226A1 (es)
RO (1) RO121701B1 (es)
RU (2) RU2247569C2 (es)
WO (1) WO2000053200A1 (es)
ZA (2) ZA200107290B (es)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
HU230800B1 (hu) * 2000-05-25 2018-06-28 Societe des Produits Nestlé S.A Új probiotikumok hobbiállat-eledel kompozíciókhoz
SE0003100D0 (sv) 2000-09-01 2000-09-01 Probi Ab New strains
SE0003576D0 (sv) * 2000-10-04 2000-10-04 Probi Ab New strain
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
SE0103695D0 (sv) 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
WO2003080813A2 (en) 2002-03-21 2003-10-02 Bifodan A/S Lactobacillus strains
JP4308481B2 (ja) * 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 抗アレルギー剤
ES2311729T5 (es) 2002-06-28 2013-02-14 Biosearch S.A. Cepas probióticas, un procedimiento para la selección de ellas, composiciones de las mismas y su uso
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
JP2004189672A (ja) * 2002-12-11 2004-07-08 Gen Corp:Kk 抗下痢症組成物
EP1759597B1 (en) * 2003-03-13 2009-01-21 Kirin Holdings Kabushiki Kaisha Probiotic composition
WO2004087891A1 (en) * 2003-04-02 2004-10-14 Axcan Pharma S.A. Lactobacillus fermentum strain and uses thereof
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
ITRM20040166A1 (it) * 2004-03-31 2004-06-30 Alberto Cresci Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
TW200637908A (en) * 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
AU2006233918B2 (en) 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
US20060263311A1 (en) * 2005-05-19 2006-11-23 Scavone Timothy A Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
EP1880001B1 (en) 2005-05-31 2011-06-08 The Iams Company Feline probiotic lactobacilli
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
MX2008010422A (es) 2006-02-15 2008-10-27 Nestec Sa Uso de bifidobacterium longum para la prevencion y tratamiento de inflamacion.
BRPI0708689A2 (pt) 2006-03-07 2011-06-07 Nestec Sa mistura simbiótica
ATE478568T1 (de) * 2007-02-02 2010-09-15 May Amadeus Alexander Produkt mit lebenden probiotischen mikroorganismen
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
US20110014167A1 (en) * 2007-07-06 2011-01-20 N.V. Nutricia Use of probiotics and fibers for diarrhoea
US20090110663A1 (en) * 2007-10-24 2009-04-30 Halow George M Method for treatment of bowel disorders
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
PL2244593T3 (pl) 2008-01-24 2015-11-30 Nestec Sa Kapsułka zawierająca składniki odżywcze i sposób dostarczania cieczy odżywczej z kapsułki
PT2265135T (pt) 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP2166083B1 (en) * 2008-12-31 2010-12-22 Syngen biotech CO., LTD. Novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof
US20100196341A1 (en) * 2009-02-05 2010-08-05 Syngen Biotech Co., Ltd. Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
CN107320480A (zh) 2009-02-24 2017-11-07 里特制药股份有限公司 益生素制剂和使用方法
JP5860396B2 (ja) * 2009-05-11 2016-02-16 ネステク ソシエテ アノニム ラクトバチルス・ジョンソニーＬａ１ＮＣＣ５３３（ＣＮＣＭＩ−１２２５）及び免疫障害
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
RU2563355C2 (ru) 2009-12-08 2015-09-20 Нестек С.А. Смесь для грудных детей с пробиотиками и компонентами оболочек жировых шариков молока
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
MY171851A (en) 2011-06-20 2019-11-04 Heinz Co Brands H J Llc Probiotic compositions and methods
US10245300B2 (en) 2012-06-18 2019-04-02 H.J. Heinz Company Brands Llc Gluten-related disorders
PL2994150T3 (pl) 2013-05-10 2019-09-30 H.J. Heinz Company Brands Llc Probiotyki i sposoby zastosowania
EP3940067A1 (en) 2014-12-05 2022-01-19 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
MX2017007148A (es) 2014-12-05 2017-10-11 Synlogic Inc Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
KR20170121291A (ko) 2015-03-02 2017-11-01 신로직 인코포레이티드 감소된 창자 염증 및/또는 강화된 창자 점막 장벽으로부터 이익을 얻는 질병을 치료하기 위해 공학처리된 박테리아
EP3294757B1 (en) 2015-05-13 2023-12-27 Synlogic Operating Company, Inc. Bacteria engineered to treat a disease or disorder
PL3294760T3 (pl) 2015-05-13 2021-11-08 Synlogic Operating Company, Inc. Zmodyfikowane bakterie do redukowania hiperfenyloalaninemii
JP6817966B2 (ja) 2015-06-10 2021-01-20 シンロジック オペレーティング カンパニー インコーポレイテッド 高アンモニア血症に関連する疾患を治療するために操作された細菌
WO2016210373A2 (en) 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
WO2016210378A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Multi-layered control of gene expression in genetically engineered bacteria
US11291693B2 (en) 2015-06-25 2022-04-05 Synlogic Operating Company, Inc. Bacteria engineered to treat metabolic diseases
WO2017023818A1 (en) 2015-07-31 2017-02-09 Synlogic, Inc. Bacteria engineered to treat disorders involving propionate catabolism
US11273184B2 (en) 2015-08-31 2022-03-15 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
WO2017075485A1 (en) 2015-10-30 2017-05-04 Synlogic, Inc. Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
CA3002965A1 (en) 2015-10-30 2017-05-04 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
CA3005451A1 (en) 2015-11-16 2017-05-26 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
WO2017123418A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
WO2017123676A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
WO2017123592A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat disorders associated with bile salts
WO2017123675A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
WO2017123610A2 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to detoxify deleterious molecules
WO2017136795A1 (en) 2016-02-04 2017-08-10 Synlogic, Inc. Bacteria engineered to treat diseases associated with tryptophan metabolism
WO2017136792A2 (en) 2016-02-04 2017-08-10 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017139708A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
WO2017139697A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
SG11201906161VA (en) 2017-01-06 2019-08-27 Synlogic Operating Co Inc Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
US10941433B2 (en) 2017-06-15 2021-03-09 Iowa State University Research Foundation, Inc. Neurotransmitter transport in probiotics
AU2018290278B2 (en) 2017-06-21 2022-12-15 Synlogic Operating Company, Inc. Bacteria for the treatment of disorders
US20200149053A1 (en) 2017-07-12 2020-05-14 Synlogic Operating Company, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
WO2019090101A1 (en) 2017-11-03 2019-05-09 Synlogic Operating Company, Inc. Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
CN110960559B (zh) * 2018-09-30 2021-02-26 内蒙古伊利实业集团股份有限公司 用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
EP3822338A4 (en) 2018-09-30 2021-08-18 Inner Mongolia Yili Industrial Group Co., Ltd. LACTOBACILLUS PARACASEI ET-22 AND USE OF IT
WO2020223345A1 (en) 2019-04-29 2020-11-05 Antipov Eugene Enumeration of genetically engineered microorganisms by live cell counting techniques
MX2022000903A (es) 2019-07-23 2022-02-14 Frieslandcampina Nederland Bv Composicion nutricional que comprende inmunoglobulina y grasa de la leche.
BR112022005578A2 (pt) 2019-09-24 2022-09-20 Prolacta Bioscience Inc Composições e métodos para tratamento de doenças inflamatórias e imunes
CA3162642A1 (en) 2019-12-24 2021-07-01 Mark Lyte Control of histamine to promote health and control enterocolitis using probiotic compositions and/or histamine degrading
CN113355252A (zh) * 2020-03-06 2021-09-07 南京卫岗乳业有限公司 一种副干酪乳杆菌及其应用
JP2023518184A (ja) 2020-03-20 2023-04-28 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を軽減するように遺伝子改変された微生物
MX2023001743A (es) 2020-08-14 2023-04-21 Prolacta Bioscience Inc Composiciones de oligosacáridos de la leche humana para usarse con bacterioterapias.
US20240110191A1 (en) 2020-12-02 2024-04-04 Synlogic Operating Company, Inc. Engineered microorganisms
WO2022146718A1 (en) 2020-12-31 2022-07-07 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia
CA3204530A1 (en) 2021-01-12 2022-07-21 Gregory Mckenzie Synbiotic treatment regimens
CN112625983B (zh) * 2021-03-05 2021-05-28 山东中科嘉亿生物工程有限公司 一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
CN112877260B (zh) * 2021-03-30 2022-08-09 江南大学 一株缓解泻剂结肠的副干酪乳杆菌及其应用
EP4323385A1 (en) 2021-04-13 2024-02-21 Synlogic Operating Company, Inc. Bacteria engineered to secrete active proteins
CN115671144A (zh) * 2021-07-26 2023-02-03 锦乔生物科技有限公司 使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
WO2023044479A1 (en) 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
WO2023245171A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
WO2023245168A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
US20230414679A1 (en) 2022-06-22 2023-12-28 Iowa State University Research Foundation, Inc. Control of histamine to promote health and control enterocolitis using probiotic compositions
WO2023250478A1 (en) 2022-06-23 2023-12-28 Synlogic Operating Company, Inc. Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
WO2024081768A1 (en) 2022-10-12 2024-04-18 Synlogic Operating Company, Inc. Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
WO2024086557A1 (en) 2022-10-17 2024-04-25 Synlogic Operating Company, Inc. Recombinant bacteria expressing phenylalanine ammonia lyase, phenylalanine transporter and l- aminoacid deaminase for reducing hyperphenylalaninemia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69219768T2 (de) * 1992-07-06 1997-08-28 Nestle Sa Milchbakterien
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
DK0760848T3 (da) * 1994-05-26 1998-09-23 Bracco Spa Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
CN1244684C (zh) * 1999-03-11 2006-03-08 雀巢制品公司 能够预防病原细菌和轮状病毒引起的腹泻的乳杆菌菌株

Also Published As

Publication number Publication date
RU2247569C2 (ru) 2005-03-10
EP1034787A1 (en) 2000-09-13
NZ513806A (en) 2003-08-29
BR0008911A (pt) 2002-01-15
AU3162700A (en) 2000-09-28
EP1162986A1 (en) 2001-12-19
PE20001557A1 (es) 2001-02-01
WO2000053200A1 (en) 2000-09-14
HK1042657A1 (zh) 2002-08-23
CN1350461A (zh) 2002-05-22
RO121701B1 (ro) 2008-02-28
NO20014299L (no) 2001-11-05
AU779414B2 (en) 2005-01-20
RU2243779C2 (ru) 2005-01-10
MY125941A (en) 2006-09-29
ZA200107290B (en) 2003-02-26
CZ20013264A3 (cs) 2002-01-16
HUP0200205A3 (en) 2002-06-28
PL355226A1 (en) 2004-04-05
US6835376B1 (en) 2004-12-28
CO5241327A1 (es) 2003-01-31
ZA200107293B (en) 2003-02-26
ID30438A (id) 2001-12-06
IL145079A (en) 2006-08-01
JP2002537865A (ja) 2002-11-12
HUP0200205A2 (hu) 2002-05-29
IL145079A0 (en) 2002-06-30
CA2364435A1 (en) 2000-09-14
NO20014299D0 (no) 2001-09-04

Similar Documents

Publication Publication Date Title
AR022912A1 (es) Una cepa de las bacterias de acido lactico que forman parte del genero lactobacillus, el uso de la misma para preparar alimentos y las formulacionesalimenticias y farmaceuticas que la contienen
AR022913A1 (es) Una bacteria de acido lactico que pertenece al genero lactobacillus, el uso de la misma para preparar alimentos y los alimentos y composicionesfarmaceuticas que la contienen
UY26734A1 (es) Nuevos probióticos para aplicaciones de alimento de mascotas
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
Di Sotto et al. Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay
UY26545A1 (es) " alimento para mascotas para tratar especies de helicobacter en mascotas."
US20080107699A1 (en) Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor
AR033574A1 (es) Una cepa bacteriana del grupo de las bacterias lacticas capaces de reducir la tendencia de un individuo a desarrollar reacciones alergicas, las composiciones alimenticias y farmaceuticas que la contienen y las vacunas que la contienen
BR0016709A (pt) Agente antiadesão da flora patogênica da pele
CL2008001382A1 (es) Metodo para preparar una composicion liofilizada aireada de frutas o vegetales que comprende: proveer un ingrediente de fruta o vegetal, incorporar un emulsificante y un mejorador de la viscosidad, pasteurizar, airear y liofilizar; composicion liofilizada aireada de frutas o vegetales.
HUP0303728A2 (hu) Tápanyagkészítmény
CL2012002013A1 (es) Microorganismos aislado thrastochytrium sp. atcc pta-10212 util en la produccion de acidos grasos omega-3
ES2165139T3 (es) Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales.
NO20063410L (no) Probiotiske tablettformuleringer
CL2021002602A1 (es) Células microbianas, métodos para producir las mismas, y usos de las mismas (divisional de la solicitud no. 201902135)
CL2019002640A1 (es) Moléculas propioticas para reducir virulencia de patógenos.
AR025045A1 (es) Composicion de ovulos intravaginales de clindamicina
BR0012992A (pt) Bifidobactérias que previnem a diarréia causada por bactérias patogênicas
ES2188521T3 (es) Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico.
AR023141A1 (es) Medio sintetico para cultivar lactobacillus y bifidobacteria
AR120748A1 (es) Preparación que comprende cepas probióticas y proceso para identificar consorcios de cepas probióticas adecuadas para la degradación del gluten
ATE536414T1 (de) Antimikrobielle wirkstoffe
WO2020055679A3 (en) A composition comprising a protein and a polyalkoxy fatty acyl surfactant
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
BR112018074913A2 (pt) formulação farmacêutica de cineol e amoxicilina

Legal Events

Date Code Title Description
FB Suspension of granting procedure